60
Participants
Start Date
January 9, 2025
Primary Completion Date
June 26, 2026
Study Completion Date
June 26, 2026
Recombinant single-chain factor VIII (rVIII-SingleChain)
Lyophilized powder for solution for intravenous injection
NOT_YET_RECRUITING
North China University of Science and Technology Affiliated Hospital, Tangshan
RECRUITING
Quinghai Provincial People's Hospital, Xining
RECRUITING
Beijing Children's Hospital, Beijing
NOT_YET_RECRUITING
Shanghai Jiaotong University School of Medicine, Ruijin Hospital, Shanghai
NOT_YET_RECRUITING
The Children's Hospital Zhejiang University School of Medicine, Shanghai
RECRUITING
Jiangxi Provincial People's Hospital, Nanchang
RECRUITING
XuZhou Children's Hospital, Xuzhou
NOT_YET_RECRUITING
The Second Hospital of Anhui Medical University, Hefei
RECRUITING
Qingdao Women and Children's Hospital, Qingdao
RECRUITING
Hospital of Hematology, Chinese Academy of Medical Sciences, Tianjin
RECRUITING
Fujian Medical University Union Hospital, Fuzhou
RECRUITING
Hunan Provincial Children's Hospital, Changsha
RECRUITING
Guangzhou Women and Children's Medical Center, Guangzhou
RECRUITING
Nanfang Hospital of Southern Medical University, Guangzhou
RECRUITING
Liuzhou People's Hospital, Liuzhou
RECRUITING
The second affiliated hospital of Kunming Medical University, Kunming
Lead Sponsor
CSL Behring
INDUSTRY